Riskpilot← Back to searchSign inGet full accessInstchemas AB
ABBankruptOrg 5565295937Other human health activities · NACE 8690Est. 19960 employees
Revenue 2019
SEK 0
EBITDA margin
—
-200% vs 2018
Equity ratio
75.7%
Financial strength
Net profit 2019
SEK -6K
-200% vs 2018
| Revenue | SEK 0 | — |
| EBITDA | SEK -6K | -200% |
| Net profit | SEK -6K | -200% |
| Total assets | SEK 115K | -5% |
| Equity | SEK 87K | -5% |
| Employees | 0 | — |
Legal name
Instchemas AB
Org number
5565295937
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
22 februari 1996
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Bolaget skall driva följande verksamhet, Utbildning av personal i kemiska laboratorier i instrumental analytisk kemi och därmed förenlig verksamhet. Utveckling av analysmetoder, instrument, dataprogram för kemiska laboratorier och därmed förenlig verksamhet. Rådgivning vid anskaffning och finansiering av laboratorie- utrustning och därmed förenlig verksamhet. Utveckling och tillverkning av system för utnyttjande av solenergi. Förvaltning av finansiella medel.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −5 | −1 | −2 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −5 | −1 | −2 | −6 |
| Net financials | — | — | — | — | — |
| Profit before tax | −3 | −5 | −1 | −2 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −5 | −1 | −2 | −6 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 132 | 133 | 137 | 121 | 115 |
| Equity | 97 | 92 | 91 | 92 | 87 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 35 | 41 | 46 | 29 | 29 |
| Total debt | 35 | 41 | 46 | 29 | 29 |
EBITDA margin
-600000.0%
This company
15.8%
Market median
-3797568% vs market
20152019
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
20152019
Return on equity
-6.9%
This company
18.4%
Market median
-138% vs market
20152019
Net profit margin
-600000.0%
This company
8.1%
Market median
-7407507% vs market
20152019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152019
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JK Liquidator | Liquidator | 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Instchemas AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Kent William Schiöld | Liquidator | 0 companies |
| Julius Eyem | Board of Directors | 0 companies |